Joseph Douglas Lyon Corcept Therapeutics Inc (CORT) insider trading activity

Joseph Douglas Lyon is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 10,066 shares of CORT, which is worth approximately $740,756. The most recent transaction as insider was on Aug 01, 2025, when has been sold 5,823 shares (Common Stock) at a price of $67.51 per share, resulting in proceeds of $393,110. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.1K

11.73% 3M change

8.35% 12M change

Total Value Held $740,756

Joseph Douglas Lyon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 01 2025	SELL Open market or private sale	$393,110 $67.51 p/Share	5,823 Reduced 36.65%	10,066 Common Stock
Aug 01 2025	BUY Exercise of conversion of derivative security	$78,959 $13.56 p/Share	5,823 Added 26.82%	15,889 Common Stock
Jul 18 2025	SELL Open market or private sale	$14,680 $73.4 p/Share	200 Reduced 1.95%	10,066 Common Stock
Jul 18 2025	BUY Exercise of conversion of derivative security	$2,712 $13.56 p/Share	200 Added 1.91%	10,266 Common Stock
Jul 17 2025	SELL Open market or private sale	$284,881 $73.48 p/Share	3,877 Reduced 27.81%	10,066 Common Stock
Jul 17 2025	BUY Exercise of conversion of derivative security	$52,572 $13.56 p/Share	3,877 Added 21.76%	13,943 Common Stock
Jul 01 2025	SELL Open market or private sale	$7,350 $73.5 p/Share	100 Reduced 0.98%	10,066 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$1,356 $13.56 p/Share	100 Added 0.97%	10,166 Common Stock
Jun 03 2025	SELL Payment of exercise price or tax liability	$31,610 $71.68 p/Share	441 Reduced 4.2%	10,066 Common Stock
Jun 02 2025	SELL Open market or private sale	$391,550 $78.31 p/Share	5,000 Reduced 35.69%	9,009 Common Stock
Jun 02 2025	BUY Exercise of conversion of derivative security	$67,800 $13.56 p/Share	5,000 Added 26.3%	14,009 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	$53,688 $35.84 p/Share	1,498 Added 12.48%	10,507 Common Stock
May 01 2025	SELL Open market or private sale	$672,825 $71.96 p/Share	9,350 Reduced 50.93%	9,009 Common Stock
May 01 2025	BUY Exercise of conversion of derivative security	$126,786 $13.56 p/Share	9,350 Added 33.74%	18,359 Common Stock
Apr 01 2025	SELL Open market or private sale	$74,444 $114.53 p/Share	650 Reduced 6.73%	9,009 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	$8,814 $13.56 p/Share	650 Added 6.31%	9,659 Common Stock
Mar 31 2025	SELL Open market or private sale	$20,272,000 $101.36 p/Share	200,000 Reduced 95.69%	9,009 Common Stock
Mar 31 2025	BUY Exercise of conversion of derivative security	$3,258,000 $16.29 p/Share	200,000 Added 48.9%	209,009 Common Stock
Mar 24 2025	SELL Open market or private sale	$25,504 $60.58 p/Share	421 Reduced 4.46%	9,009 Common Stock
Mar 24 2025	BUY Exercise of conversion of derivative security	$5,708 $13.56 p/Share	421 Added 4.27%	9,430 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$11,025 $60.58 p/Share	182 Reduced 2.08%	8,577 Common Stock
Mar 03 2025	SELL Open market or private sale	$277,899 $60.69 p/Share	4,579 Reduced 33.7%	9,009 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$62,091 $13.56 p/Share	4,579 Added 25.21%	13,588 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	$12,761 $29.54 p/Share	432 Added 4.58%	9,009 Common Stock
Feb 03 2025	SELL Open market or private sale	$334,600 $66.92 p/Share	5,000 Reduced 36.34%	8,759 Common Stock

JDL

Joseph Douglas Lyon

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account